skip to main content

Valproate original-pack safety information — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

HardDispensing and SupplyValproate original-pack safety informationGPhC CRA

A prescription for sodium valproate modified-release tablets is presented for a 23-year-old woman. The pharmacy stock pack contains manufacturer warnings and a patient card; the prescription is for a quantity that would require split-pack dispensing. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: E — Supply with the required safety materials and avoid repackaging that omits warnings

Valproate has major reproductive risks and supply should preserve manufacturer warnings and patient information wherever possible. Patients who can become pregnant require pregnancy prevention programme checks and counselling, but existing treatment should not be abruptly refused without clinical liaison. Splitting packs must not remove critical safety information.

Reference: MHRA; BNF; MEP